| Subscribe To Our Free Newsletter |
Alembic Pharma Q2 Results: Net profit rises 12% to Rs 153 crore, revenue up 3%
Alembic Pharma reported a 12% YoY rise in Q2FY25 net profit to Rs 153 crore, driven by strong domestic and US market sales. Revenues grew 3% to Rs 1648 crore, while EBITDA declined 6%, with margins at 15.6%
